Reaction
Malignant Melanoma Stage Iv reporting signals
As of the last recalculation, Malignant Melanoma Stage Iv appears in 281 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is DABRAFENIB (PRR 251.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dabrafenib | 57 | 251.1 | 251.8 |
| Trametinib | 56 | 214.1 | 214.6 |
| Sildenafil Citrate | 103 | 94.0 | 94.1 |
| Tadalafil | 79 | 80.9 | 81.0 |
| Vemurafenib | 6 | 37.8 | 37.8 |